Serum erythropoietin levels in 696 patients investigated for erythrocytosis with JAK2 mutation analysis
Open Access
- 19 January 2022
- journal article
- letter
- Published by Wiley in American Journal of Hematology
- Vol. 97 (4) , E150-E153
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- A Prediction Rule to Guide JAK2 Testing in Patients with Suspected Polycythemia VeraBlood, 2021
- Cause‐specific mortality following polycythemia vera, essential thrombocythemia, and primary myelofibrosis in the US population, 2001–2017American Journal of Hematology, 2021
- Polycythemia vera and essential thrombocythemia: 2021 update on diagnosis, risk‐stratification and managementAmerican Journal of Hematology, 2020
- Investigation and management of erythrocytosisCanadian Medical Association Journal, 2020
- The role of a low erythropoietin level for the polycythemia vera diagnosisBlood Cells, Molecules, and Diseases, 2020
- Laboratory Investigation of Myeloproliferative Neoplasms (MPNs)American Journal of Clinical Pathology, 2016
- How I treat polycythemia veraBlood, 2014